Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes.
J Diabetes Sci Technol
; 18(3): 733-740, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38292004
ABSTRACT
The Biomarkers for the Diagnosis of Heart Failure in Diabetes webinar was hosted by Diabetes Technology Society on September 20, 2023, with the objective to review current evidence and management practices of biomarker screening for heart failure in people with diabetes. The webinar discussed (1) the four stages of heart failure, (2) diabetes and heart failure, (3) natriuretic peptide and troponin for diagnosing heart failure in diabetes, (4) emerging composite and investigational biomarkers for diagnosing heart failure, and (5) prevention of heart failure progression. Experts in heart failure from the fields of clinical chemistry, cardiology, and diabetology presented data about the importance of screening for heart failure as an often-unnoticed complication of people with type 1 and type 2 diabetes.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Biomarkers
/
Heart Failure
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
J Diabetes Sci Technol
Journal subject:
ENDOCRINOLOGIA
Year:
2024
Type:
Article
Affiliation country:
United States